Amundi Boosts Stake in H.B. Fuller (NYSE:FUL)

Amundi boosted its stake in shares of H.B. Fuller (NYSE:FUL) by 191.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,553 shares of the specialty chemicals company’s stock after purchasing an additional 18,771 shares during the period. Amundi owned about 0.05% of H.B. Fuller worth $1,804,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Geode Capital Management LLC raised its stake in shares of H.B. Fuller by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after buying an additional 18,734 shares during the period. Lord Abbett & CO. LLC increased its holdings in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after acquiring an additional 324,056 shares in the last quarter. Wesbanco Bank Inc. raised its stake in H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after acquiring an additional 4,000 shares during the period. Bank of New York Mellon Corp lifted its holdings in H.B. Fuller by 17.2% during the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after purchasing an additional 81,558 shares in the last quarter. Finally, Jones Financial Companies Lllp boosted its position in shares of H.B. Fuller by 128.8% in the fourth quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company’s stock worth $61,000 after purchasing an additional 506 shares during the period. 95.93% of the stock is currently owned by hedge funds and other institutional investors.

H.B. Fuller Stock Performance

NYSE FUL opened at $54.01 on Tuesday. The stock has a market capitalization of $2.93 billion, a PE ratio of 23.38, a P/E/G ratio of 1.13 and a beta of 1.41. H.B. Fuller has a 1-year low of $52.59 and a 1-year high of $87.67. The business has a 50 day simple moving average of $59.82 and a two-hundred day simple moving average of $70.32. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16.

H.B. Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). The business had revenue of $923.00 million during the quarter, compared to the consensus estimate of $916.84 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The company’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 EPS. On average, research analysts predict that H.B. Fuller will post 4.07 EPS for the current fiscal year.

H.B. Fuller Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th were given a dividend of $0.2225 per share. This represents a $0.89 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Thursday, February 6th. H.B. Fuller’s dividend payout ratio is 38.53%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. JPMorgan Chase & Co. decreased their price objective on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Seaport Res Ptn downgraded H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Citigroup cut their target price on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Deutsche Bank Aktiengesellschaft lowered their price target on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd. Finally, Vertical Research lowered shares of H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $75.60.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.